N-Phenylphenylglycines as Novel Corticotropin Releasing Factor Receptor Antagonists

Journal of Medicinal Chemistry

Volumn 47, Issue 10, 2004, Pages 2426-2429

  Molteni, Valentina ^a   Penzotti, Julie ^a   Wilson, Dean M ^a   Termin, Andreas P ^a   Mao, Long ^a   Crane, Christine M ^a   Hassman, Fred ^a   Wang, Tao ^a   Wong, Harvey ^b   Miller, Keith J ^b   Grossman, Scott ^b   Grootenhuis, Peter D J ^a  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; N PHENYLPHENYLGLYCINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SCREENING; ENANTIOMER; STEREOCHEMISTRY;

ANIMALS; COMBINATORIAL CHEMISTRY TECHNIQUES; DOGS; DRUG DESIGN; GLYCINE; HUMANS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 2342557320     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm049974i     Document Type: Article

References (20)

1. Vale, W.; Spiess, J.; Rivier, C.; Rivier, J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981, 213, 1394-1397.
2. Gilligan, P. J.; Robertson, D. W.; Zaczeck, R. Corticotropin releasing factor (CRF) receptor modulators: progress and opportunities for new therapeutic agents. J. Med. Chem. 2000, 43, 1641-1660 and references therein.
3. Aguilera, G. Corticotropin releasing hormone, receptor regulation and the stress response. Trends Endocrinol. Metab. 1998, 9, 329-336.
4. Koob, G. F. Stress, corticotropin-releasing factor, and drug addiction. Ann. N. Y. Acad. Sci. 1999, 897, 27-45.
5. Pelleymounter, M. A.; Joppa, M.; Carmouche, M.; Cullen, M. J.; Brown, B. ; Murphy, B.; Grigoriadis, D. E.; Ling, N.; Foster, A. C. Role of corticotropin-releasing factor (CRF) receptors in the anorexic syndrome induced by CRF. J. Pharmacol. Exp. Ther. 2000, 293, 799-806.
6. Kaye, W. H. Neuropeptide abnormalities in anorexia nervosa. Psychiatry Res. 1996, 62, 65-74.
7. Keller, P. A.; Elfick, L.; Garner, J.; Morgan, J.; McCluskey, A. Corticotropin releasing-hormone: therapeutic implications and medicinal chemistry developments. Bioorg. Med. Chem. 2000, 8, 1213-1223.
8. 1 receptor: design of small molecule inhibitors, receptor subtypes, and clinical indications. Curr. Pharm. Des. 1999, 5, 289-315.
9. Saunders, J.; Williams, J. New developments in the study of corticotropin releasing factor. Annu. Rep. Med. Chem. 2001, 36, 21-30 and references therein.
10. Wilson, D. M.; Termin, A. P.; Mao, L.; Ramirez-Weinhouse, M. M.; Molteni, V.; Grootenhuis, P. D. J.; Miller, K.; Keim, S.; Wise, G. Arylamidrazones as novel corticotropin releasing factor receptor antagonists. J. Med. Chem. 2002, 45, 2123-2126.
11. Srinivasan, J.; Castellino, A.; Bradley, E. K.; Eksterowicz, J. D.; Grootenhuis, P. D. J.; Putta, S.; Stanton, R. V. Evaluation of a novel shape-based computational filter for lead evolution: application to thrombin inhibitors. J. Med. Chem. 2002, 45 (12), 2494-2500.
12. Miller, J. L.; Bradley, E. K.; Teig, S. L. Luddite: an information-theoretic library design tool. J. Chem. Inf Comput. Sci. 2003, 4347-54.
13. (a) Petasis, N. A.; Zavialov, I. A. A new and practical synthesis of α-amino acids from alkenyl boronic acids. J. Am. Chem. Soc. 1997, 119, 445-446.
14. (b) Petasis, N. A.; Goodman, A.; Zavialov, I. A new synthesis of α-arylglycines from aryl boronic acids. Tetrahedron 1997, 53, 16463-16470.
15. (c) Petasis, N. A.; Zavialov, I. Highly stereocontrolled one-step synthesis of anti-β-amino alcohols from organoboronic acids, amines, and α-hydroxy aldehydes. J. Am. Chem. Soc. 1998, 120, 11798-11799.
16. Zeng, L.; Kassel, D. B. Anal. Chem. 1998, 70, 4380.
17. (a) Arvanitis, A. G.; Gilligan, P. J.; Chorvat, R. J.; Cheeseman, R. S.; Christos, T. E.; Bakthavatchalam, R.; Beck, J. P.; Cocuzza, A. J.; Hobbs, F. W. ; Wilde, R. G.; Arnold, C.; Chidester, D.; Curry, M.; He, L.; Hollis, A.; Klaczkiewicz, J.; Krenitsky, P. J.; Rescinito, J. P.; Scholfield, E.; Culp, S.; De Souza, E. B.; Fitzgerald, L.; Grigoriadis, D.; Tam, S. W.; Wong, Y. N.; Huang, S.; Shen, H.-S. L. Non-peptide corticotropin releasing hormone antagonists: syntheses and structure-activity relationships of 2-anilino-pyrimidines and -triazines. J. Med. Chem. 1999, 42, 805-818.
18. i values exceeded 15%, additional duplicate studies were performed until this criterion was met and determinations were averaged. Internal control compounds were run on every plate.
19. (a) Berman, J.; Halm, K.; Adkison, K.; Schaffer, J. Simultaneous pharmacokinetic screening of a mixture of compounds in dog using API LC/MS/MS analysis for increased throughput J. Med. Chem. 1997, 40, 827-829.
20. 1 receptor antagonist. J. Med. Chem. 2000, 43, 449-456.